Patients / Clinical Trials / Advancing Inclusive Research / External Council Members

External Council Members

Otis Brawley, MD
Bloomberg Distinguished Professor, Johns Hopkins University

John Carpten, PhD
Professor & Chair, Department of Translational Genomics, and Director, Institute for Translational Genomics Keck School of Medicine, USC

Keith D. Carter, MD
Chairman and Head, Department of Ophthalmology, University of Iowa; Past President of the American Academy of Ophthalmology

Joseph Coney, MD
Ophthalmologist & Retinal Specialist, Retina Associates of Cleveland, Case Western Reserve and University Hospital

Andrea Ferris, MBA
President & Chief Executive Officer, LUNGevity Foundation

Owen Garrick, MD, MBA
Vice President of Clinical Trial Delivery, CVS Health Clinical Trial Services

Edward S. Kim, MD, FACP, FASCO
Physician-in-Chief and Senior Vice President, City of Hope Orange County, and Vice Physician-in-Chief, City of Hope National Medical Center

Ruben A. Mesa, MD, FACP
Enterprise Senior Vice President, Atrium Health, and Vice Dean for Cancer Programs, Wake Forest University School of Medicine

Edith Mitchell, MD, MACP, FCPP
Sidney Kimmel Cancer Center at Jefferson

Stephanie Monroe, JD
Executive Director, UsAgainstAlzheimer’s African American Network

Edith Perez, MD
Director, Translational Genomics Program, Mayo Clinic Breast Cancer

Fabian Sandoval, MD
President & Chief Executive Officer, Emerson Clinical Research Institute

Mitzi Williams, MD
Neurologist & MS Specialist, Joi Life Wellness Group, Department of Neurology, Emory University

Robert Winn, MD
Director NCI Cancer Center, Virginia Commonwealth University, Massey Cancer Center

Genentech Committee Members

Quita Highsmith, MBA
Vice President and Chief Diversity Officer

Nicole Richie, PhD
Global Head Health Equity Science and Strategy, Co-Lead, Advancing Inclusive Research

Veronica Sandoval, PhD, JD
Principal, Patient Inclusion & Health Equity

Gerren Wilson, PharmD
Respiratory Franchise Lead

Pierre Theodore
Head, Patient Inclusion & Health Equity

Access to Investigational Medicines
We're committed to a fair and impartial evaluation of each request for access to our investigational medicines.
Genentech Access Solutions
Focusing on access, so you can focus on health.
Resilience Effect
Learn about our philanthropic initiative to take on childhood adversity in the Bay Area.

Attention: This page may not render properly. The browser you are using, Internet Explorer 10, is no longer supported.

External Council Members

Genentech Committee Members

You Might Also Be Interested In